Antengene presents first ATG-207 preclinical data at EULAR 2026

Gilead and Lakefront complete Ouro Medicines acquisition to expand autoimmune disease pipeline

Breckenridge launches Tofacitinib Tablets, generic equivalent to Pfizer's Xeljanz

HotSpot Therapeutics presents preclinical data from small molecule IRF5 inhibitor programme at EULAR 2026

UCB launches scholarship program for adults living with hidradenitis suppurativa

Upsher-Smith launches generic Cyclosporine Ophthalmic Emulsion 0.05%

Accro Bioscience completes USD50m Series C financing

Atisama Therapeutics reports progress in Phase 1 study of RB042

Mabwell's clinical trial application for 9MW5211 cleared by US FDA

Specialised Therapeutics' chronic graft-versus-host disease therapy approved in Australia

Insilico's Rentosertib inhalation solution receives IND clearance to enter direct-to-lung clinical study

GSK secures US and EU fast-track designations for efimosfermin in MASH

FDA expands Sanofi and Regeneron's Dupixent approval to younger children with chronic spontaneous urticaria

AstraZeneca reports third positive Phase III trial for tozorakimab in COPD

GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma